Company / Capital Returned to Shareholders
CorVel Corporation Capital Returned to Shareholders History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$37.6M
FY2024
5-year range
$37.6M / $93.7M
FY2020-FY2024
Trend
-17.7%
vs FY2023
Sector context
#70 of 103
Health Care
What the data says
At $38M, CorVel Corporation's capital returned to shareholders ranks #70 of 103 in the Health Care sector. Capital Returned to Shareholders has fluctuated over the past 9 years, ranging from $11M in FY2017 to $94M in FY2022.
Based on SEC 10-K filings.
$38M in FY2024 with a 5-year CAGR of -10.5%.
Declined from $94M to $38M over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -25.3%
- 5-Year CAGR
- -10.5%
- 10-Year CAGR
- -
Sector benchmark
-94.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.5%, indicating a declining trend.
- In FY2024, capital returned to shareholders decreased 17.7% year-over-year.
- Ranks #70 out of 103 companies in the Health Care sector.
- Peak capital returned to shareholders was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $37.6M | -17.7% |
| FY2023 | $45.7M | -51.2% |
| FY2022 | $93.7M | +4.0% |
| FY2021 | $90.1M | +175.7% |
| FY2020 | $32.7M | -50.2% |
| FY2019 | $65.6M | +86.6% |
| FY2018 | $35.2M | +214.4% |
| FY2017 | $11.2M | -60.0% |
| FY2016 | $28.0M | -11.2% |
As of FY2024 · SEC 10-K · Updated Mar 29, 2026